Hemostatic Agents Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Hemostatic Agents Market
Hemostatic Agents Market: By Type (Thrombin, Oxidized Regenerated Cellulose, Combination, Gelatin, Collagen, Fibrin Sealants); By Treatment (Cardiovascular, General, Digestive, Neurological); By End User (Hospitals, Surgical Centers, Nursing Homes) & Geography - Forecast (2016-2022)
Report Code : HCR 0091
Updated Date: 11 June, 2018  
18

Copies sold

    Client Rating

1. Hemostatic Agents Market Overview
2. Hemostatic Agents Market Executive Summary
3. Hemostatic Agents Market Landscape 
   3.1. Market Share Analysis
   3.2. Financial Analysis
   3.3. End User Profiling
   3.4. Product Benchmarking
   3.5. Patent Analysis 
4. Hemostatic Agents Market Forces
   4.1. Market Drivers
   4.2. Market Constraints & Challenges
   4.3. Attractiveness of Hemostatic Agents Market 
      4.3.1. Power of Suppliers
      4.3.2. Power of Buyers
      4.3.3. Threat of Substitutes
      4.3.4. Threat of New entrants
      4.3.5. Degree of Competitive Rivalry
5. Hemostatic Agents Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Opportunities Analysis
   5.3. Market Life Cycle Analysis
   5.4. Pricing Analysis
6. Hemostatic Agents Market –  By Type
   6.1. Introduction 
   6.2. Thrombin Based Hemostats
   6.3. Gelatin Based Hemostats
   6.4. Collagen Based Hemostats
   6.5. Oxidized Regenerated Cellulose Based Hemostats
   6.6. Combination Hemostats
   6.7. Fibrin Sealants
   6.8. Others
7. Hemostatic Agents Market –  By Treatment
   7.1. Introduction
   7.2. Cardiovascular
   7.3. General Surgery
   7.4. Digestive Surgery
   7.5. Neurosurgery
   7.6. Others
8. Hemostatic Agents Market – By End User
   8.1. Introduction
   8.2. Hospitals
   8.3. Surgery Centers
   8.4. Nursing Homes
   8.5. Others
9. Hemostatic Agents Market -Geographic Analysis
   9.1. Introduction
   9.2. Americas 
      9.2.1. U.S
      9.2.2. Canada 
      9.2.3. Mexico
      9.2.4. Brazil
      9.2.5. Rest of Americas
   9.3. Europe
      9.3.1. U.K.
      9.3.2. Germany
      9.3.3. France
      9.3.4. Italy
      9.3.5. Rest of Europe
   9.4. Asia-Pacific
      9.4.1. China
      9.4.2. Japan
      9.4.3. India
      9.4.4. Australia & New Zealand
      9.4.5. South Korea
      9.4.6. Rest of APAC
   9.5. RoW
      9.5.1. Africa
      9.5.2. Middle East                      
10. Hemostatic Agents Market Entropy
11. Hemostatic Agents Market Company Profiles 
   11.1. Baxter International  Incorporation (U.S.)
   11.2. C.R. Bard Incorporation (U.S.)
   11.3. B.Braun Melsungen AG (Germany)
   11.4. Integra Life Sciences Corporation (U.S.)
   11.5. Equimedical (Netherlands)
   11.6. Marine Polymer Technologies (U.S.)
   11.7. Gelita GmbH (Germany)
   11.8. Johnson and Johnson Services Inc (U.S.)
   11.9. Pfizer Inc (U.S.)
   11.10. Advanced Medical Solutions Group (U.K.)
   11.11. Vascular Solutions, Inc (U.S.)
   11.12. Z-Medica LLC (U.S.)
   11.13. Mallinckrodt Plc (U.S.)
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll